Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the instagram-feed domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in C:\Shares\websites\innovate.research.ufl.edu\wp-includes\functions.php on line 6121 Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the feeds-for-youtube domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in C:\Shares\websites\innovate.research.ufl.edu\wp-includes\functions.php on line 6121 Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the limoking domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in C:\Shares\websites\innovate.research.ufl.edu\wp-includes\functions.php on line 6121 National Resilience Snares Takeda Plasma Development and Manufacturing Deal – UF Innovate
University of Florida word mark
Community Calendar for Entrepreneurs

National Resilience Snares Takeda Plasma Development and Manufacturing Deal (Fierce Pharma)

National Resilience Snares Takeda Plasma Development and Manufacturing Deal

Manufacturing newcomer National Resilience, already working on Moderna’s COVID-19 vaccine in Canada, has enlisted another high-profile client.

Resilience has clinched a deal to chip in on development and manufacturing of “multiple” products in Takeda’s plasma-derived therapies portfolio, the company said Tuesday. It plans to tackle the project from its 136,000-square-foot biomanufacturing plant in Mississauga, Ontario. 

In April 2021, the company acquired biologic drug substance maker Ology Bioservices, a UF startup and graduate of UF Innovate | Accelerate at Sid Martin Biotech. That deal bolstered Resilience’s biopharma production network with the addition of 300 new employees and 200,000-square-feet of workspace.

Read more about National Resilience Snares Takeda Plasma Development and Manufacturing Deal.
LinkedIn